RSH-7
RSH-7 is a potent BTK and FLT3 inhibitor with IC50s of 47, 12 nM, respectively. RSH-7 induces apoptosis and shows antiproliferative activities. RSH-7 inhibits BTK and FLT3 signaling and shows anti-tumor activity[1].
Product Specifications
CAS Number
2764609-97-2
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Btk; FLT3
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rsh-7.html
Purity
99.07
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC(NC4=C(C=CC=C4)C(NN)=O)=C(C=N3)F
Molecular Formula
C22H25FN8O
Molecular Weight
436.49
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Ran F, et al. Development of novel hydrazidoarylaminopyrimidine-based BTK/FLT3 dual inhibitors with potent in vivo anti-hematological malignancies effects. Eur J Med Chem. 2023 Jan 5;245 (Pt 1) :114913.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Anti-Atg16L1 Antibody [JU30-62]](https://cdn.genprice.uk/products/992/68dd1c8d061270361ea81ea0/imageurl01/et7106-65tr.webp)
![FOXC2 Mouse Monoclonal Antibody [Clone ID: OTI3E3]](https://cdn.genprice.uk/products/937/68dd18b9061270361e908156/imageurl/cf807700.webp)